Published in Br J Pharmacol on December 01, 2015
Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma | NCT01952769
Butein provides neuroprotective and anti-neuroinflammatory effects through Nrf2/ARE-dependent haem oxygenase 1 expression by activating the PI3K/Akt pathway. Br J Pharmacol (2016) 1.43
Impact of concomitant medications on obstructive sleep apnoea. Br J Clin Pharmacol (2016) 0.94
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18. Br J Pharmacol (2016) 0.91
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol (2016) 0.85
A New Nomenclature for Classifying Psychotropic Drugs. Br J Clin Pharmacol (2017) 0.84
Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1. Br J Pharmacol (2016) 0.84
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio(®) ) in cardiac surgery: the REVAKI-1 study. Br J Clin Pharmacol (2016) 0.82
The role of perivascular adipose tissue in obesity-induced vascular dysfunction. Br J Pharmacol (2016) 0.82
The Warburg effect and drug resistance. Br J Pharmacol (2016) 0.81
Deletion of AMPKα1 attenuates the anticontractile effect of perivascular adipose tissue (PVAT) and reduces adiponectin release. Br J Pharmacol (2016) 0.81
Comparisons between perivascular adipose tissue and the endothelium in their modulation of vascular tone. Br J Pharmacol (2016) 0.80
GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its auto-injector device with pre-filled syringes. Br J Clin Pharmacol (2016) 0.79
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. Br J Pharmacol (2017) 0.79
Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol (2017) 0.79
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine. Br J Pharmacol (2016) 0.79
The pro-cognitive mechanisms of physical exercise in people with schizophrenia. Br J Pharmacol (2017) 0.79
Increased mitochondrial ROS generation mediates the loss of PVAT anticontractile effect in HFD-treated obese mice. Br J Pharmacol (2016) 0.79
Applications of chemogenomic library screening in drug discovery. Nat Rev Drug Discov (2017) 0.79
Adiponectin improves endothelial function in mesenteric arteries of rats fed a high-fat diet: role of perivascular adipose tissue. Br J Pharmacol (2017) 0.79
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab. Br J Clin Pharmacol (2016) 0.79
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment. Br J Pharmacol (2017) 0.79
Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia. Br J Clin Pharmacol (2016) 0.78
An update on PPAR activation by cannabinoids. Br J Pharmacol (2016) 0.78
Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects. Br J Pharmacol (2016) 0.78
Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes. Br J Pharmacol (2016) 0.77
Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon. Br J Pharmacol (2016) 0.77
Snapshot: implications for melatonin in endoplasmic reticulum homeostasis. Br J Pharmacol (2016) 0.77
Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists. Br J Pharmacol (2016) 0.77
The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model. Br J Pharmacol (2016) 0.77
Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callus. Br J Pharmacol (2016) 0.77
Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes. Br J Pharmacol (2016) 0.77
Differences in ion channel phenotype and function between humans and animal models. Front Biosci (Landmark Ed) (2018) 0.77
Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction. Br J Pharmacol (2016) 0.76
Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review. Br J Pharmacol (2016) 0.76
Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol (2016) 0.76
Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases. Br J Pharmacol (2016) 0.76
First-in-human randomised study of bimekizumab, a humanised monoclonal antibody and selective dual inhibitor of IL-17A and IL-17 F, in mild psoriasis. Br J Clin Pharmacol (2016) 0.76
Poor reporting and documentation in drug-associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis - Lessons for medication safety. Br J Clin Pharmacol (2016) 0.76
The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease. Br J Pharmacol (2016) 0.76
Ribosomal Protein S3 Gene Silencing Protects Against Experimental Allergic Asthma. Br J Pharmacol (2017) 0.75
Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth. Br J Pharmacol (2016) 0.75
Effect of Ketoconazole, a Strong CYP3A Inhibitor, on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor, in Patients with Non-Hodgkin Lymphoma. Br J Clin Pharmacol (2016) 0.75
Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Br J Clin Pharmacol (2016) 0.75
Novel putative pharmacologic therapies to protect the right ventricle in pulmonary hypertension: A review of current literature. Br J Pharmacol (2017) 0.75
Remote ischaemic preconditioning suppresses endogenous plasma nitrite during ischaemia-reperfusion: a randomised controlled crossover pilot study. Br J Clin Pharmacol (2017) 0.75
Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis. Br J Pharmacol (2016) 0.75
Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation. Br J Pharmacol (2016) 0.75
Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects. Br J Clin Pharmacol (2017) 0.75
The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration. Br J Pharmacol (2016) 0.75
Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer. Br J Pharmacol (2017) 0.75
Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers. Br J Pharmacol (2016) 0.75
Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis. Br J Clin Pharmacol (2017) 0.75
Rapid Antidepressant Effect of Ketamine Correlates with Astroglial Plasticity in the Hippocampus. Br J Pharmacol (2017) 0.75
Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization. Br J Pharmacol (2016) 0.75
Development of an in vivo target-engagement biomarker for TRPA1 antagonists in humans. Br J Clin Pharmacol (2016) 0.75
Zebrafish models in neuropsychopharmacology and CNS drug discovery. Br J Pharmacol (2017) 0.75
PGE2 /EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy. Br J Pharmacol (2017) 0.75
Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22. Br J Pharmacol (2017) 0.75
Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period. Br J Clin Pharmacol (2016) 0.75
Immunology proves a great success for treating systemic autoimmune diseases - a perspective on immunopharmacology: IUPHAR Review 23. Br J Pharmacol (2017) 0.75
An original pharmacoepidemiologic - pharmacodynamic method: application to antipsychotic-induced movement disorders. Br J Clin Pharmacol (2016) 0.75
Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view. Br J Pharmacol (2016) 0.75
Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of AKT1 signaling pathway. Br J Pharmacol (2017) 0.75
Anti-CD22 and anti-CD79b antibody-drug conjugates preferentially target proliferating B cells. Br J Pharmacol (2017) 0.75
Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-DNA damage. Br J Pharmacol (2016) 0.75
Effects of anthocyanins on the prevention and treatment of cancer. Br J Pharmacol (2016) 0.75
The calcium-cancer signalling nexus. Nat Rev Cancer (2017) 0.75
Inhibition of fatty acid synthase is protective in pulmonary hypertension. Br J Pharmacol (2016) 0.75
Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis. Br J Pharmacol (2016) 0.75
Microtubule destabilising agents: far more than just antimitotic anticancer drugs. Br J Clin Pharmacol (2016) 0.75
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. Br J Pharmacol (2017) 0.75
Gene Therapy with Mesenchymal Stem Cells Expressing IFNßAmeliorates Neuroinflammation in Experimental Models of Multiple Sclerosis. Br J Pharmacol (2016) 0.75
A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol (2016) 0.75
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol (2016) 0.75
The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. Br J Pharmacol (2017) 0.75
Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy. Front Pharmacol (2017) 0.75
Pharmacokinetics of obinutuzumab in Chinese patients with B-cell lymphomas. Br J Clin Pharmacol (2017) 0.75
Ginkgolide K protects the heart against endoplasmic reticulum stress injury by activating the inositol-requiring enzyme 1α/X box-binding protein-1 pathway. Br J Pharmacol (2016) 0.75
Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes. Sci Rep (2016) 0.75
The evolution of RGS proteins as drug targets - 20 years in the making. IUPHAR Review: "X". Br J Pharmacol (2017) 0.75
Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity. Br J Pharmacol (2016) 0.75
Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy. PLoS One (2017) 0.75
An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis. Br J Pharmacol (2016) 0.75
Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel Pore. Mol Pharmacol (2017) 0.75
Utilizing melatonin to combat bacterial infections and septic injury. Br J Pharmacol (2017) 0.75
Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator. Br J Clin Pharmacol (2016) 0.75
Accelerating the search for the missing proteins in the human proteome. Nat Commun (2017) 0.75
Big conductance calcium-activated potassium channel openers control spasticity without sedation. Br J Pharmacol (2017) 0.75
Sex differences in the regulation of porcine coronary artery tone by perivascular adipose tissue: a role of adiponectin? Br J Pharmacol (2017) 0.75
Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study. Br J Clin Pharmacol (2017) 0.75
Dual CDK4/6 Inhibition by PD-0332991 induces apoptosis and senescence in esophageal squamous cell carcinoma cells. Br J Pharmacol (2017) 0.75
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via SHP-1-STAT3-survivin cascade. Br J Pharmacol (2017) 0.75
COX-2-selective inhibitors celecoxib and deracoxib modulate TRPV3 channels. Br J Pharmacol (2017) 0.75
Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington Disease. Br J Clin Pharmacol (2017) 0.75
Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial. Br J Clin Pharmacol (2017) 0.75
NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tPA-induced haemorrhagic transformation after cerebral ischemia. Br J Pharmacol (2017) 0.75
Pharmacogenomics of off-target adverse drug reactions. Br J Clin Pharmacol (2017) 0.75
Pterostilbene reduces oxidative stress, prevents hypertrophy and preserves systolic function of right ventricle in cor pulmonale model. Br J Pharmacol (2017) 0.75
In silico analysis of the transportome in human pancreatic ductal adenocarcinoma. Eur Biophys J (2016) 0.75
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res (2015) 10.66
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol (2015) 5.96
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol (2013) 5.57
The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol (2015) 4.28
The Concise Guide to PHARMACOLOGY 2013/14: ion channels. Br J Pharmacol (2013) 3.03
The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol (2015) 2.74
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors. Br J Pharmacol (2013) 2.29
The Concise Guide to PHARMACOLOGY 2013/14: transporters. Br J Pharmacol (2013) 2.07
The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology (Berl) (2014) 2.01
The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels. Br J Pharmacol (2015) 1.88
The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels. Br J Pharmacol (2013) 1.88
The Concise Guide to PHARMACOLOGY 2013/14: nuclear hormone receptors. Br J Pharmacol (2013) 1.70
The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol (2015) 1.66
The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol (2015) 1.62
The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. Br J Pharmacol (2015) 1.30
The Concise Guide to PHARMACOLOGY 2015/16: Other ion channels. Br J Pharmacol (2015) 0.98